Seeking Alpha

BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for...

BioMarin Pharmaceutical (BMRN +3.4%) gets a lift after announcing it's received FDA approval for the expansion of its manufacturing facility in Novato, CA. The facility will support will the company's enzyme replacement therapy portfolio, and provide up to $1B in revenue.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|